HOME >> MEDICINE >> NEWS
Tumor cell activity may provide clues for treating breast cancer in young women

DURHAM, N.C. -- When women under 50 develop breast cancer the disease tends to be more aggressive and less responsive to treatment than when it occurs in older women. Researchers at the Duke Institute for Genome Sciences & Policy and the Duke University Comprehensive Cancer Center may have discovered a part of the reason why, and their findings may lead to targeted therapies that can help treat patients more effectively.

The researchers discovered that the tumors found in women under the age of 45 have certain patterns of cellular activity that confer a poorer prognosis in younger women, while the same tumor cell activity in older women confers a better prognosis, demonstrating the need for age-appropriate targeted therapies, said Carey Anders, M.D., a fellow in hematology-oncology at Duke and lead investigator on the study. For this study, researchers focused on women under the age of 45 because they were seeking to gather information specific to premenopausal women.

The researchers will present their findings in a poster discussion session on Sunday, June 3, at the American Society of Clinical Oncology annual meeting in Chicago. The study was funded by the National Institutes of Health.

During the process by which cells change and become cancerous, we saw certain patterns in young womens tumors that we didnt see in the tumors found in women over the age of 45, Anders said. If we are able to inhibit these processes by using drugs -- some of which are already available and being used to treat other cancers -- we might have a better chance at treating these women more effectively and possibly even curing them.

Research is currently under way to determine what therapies might be effective in targeting the cellular activity in young womens tumors, with the hope of shutting it down and halting tumor growth.

More than 200,000 women were diagnosed with breast cancer in 2006, and about 22 percent -- or approximately 46
'"/>

Contact: Lauren Shaftel
lauren.shaftel@duke.edu
919-684-4966
Duke University Medical Center
3-Jun-2007


Page: 1 2

Related medicine news :

1. Tumor necrosis factor blockers may not cause cancer after all
2. Tumor size related to lung cancer spread
3. Tumor detection, data encryption to benefit from UH research
4. ADHD appears to be associated with depressed dopamine activity in the brain
5. Drug shows activity against brain metastases
6. Vorinostat shows anti-cancer activity in recurrent gliomas
7. VEGF Trap shows activity in patients with advanced ovarian cancer
8. Study supports activity of GEMZAR in the treatment of early-stage breast cancer
9. Brain activity reflects differences in types of anxiety
10. Star Trek-type scanning may reveal genetic activity of tumors, Stanford study shows
11. Low physical activity can improve fitness levels for sedentary, overweight postmenopausal women

Post Your Comments:
(Date:5/20/2013)... 20, 2013 Mobile Health partnered ... to patients without health insurance in their New ... network of over 59,000 pharmacies nationwide, including many ... The prescription discount cards are available in all ... In 2012, Mobile Health screened 250,000 individuals for ...
(Date:5/20/2013)... HealthDay Reporter , , SATURDAY, May 18 (HealthDay News) ... view during colonoscopies may help them miss fewer suspicious ... Colonoscopies are the recommended screening tests for colorectal cancer, ... and women in the United States. To perform ... a camera mounted on the end called a colonoscope ...
(Date:5/20/2013)... May 20 (HealthDay News) -- If you,ve got bunions, ... common foot disorder, with a new study finding the ... Reporting in the May issue of Arthritis ... European descent often inherit conditions such as bunions or ... investigation of the heritability of common foot disorders in ...
(Date:5/20/2013)... inflammatory bowel disease (IBD) are at higher risk of ... Mayo Clinic. Researchers found that IBD is associated with ... findings were presented at the Digestive Disease Week 2013 ... Americans have Crohn,s disease or ulcerative colitis (UC), the ... inflame the lining of the intestine, leading to bouts ...
(Date:5/20/2013)... HI (PRWEB) May 20, 2013 Maui’d Forever ... planner and coordinator. Founded in 2003 by entrepreneur Mark Steffan, ... Kauai and the Big Island of Hawaii. They use over ... add additional members to their team. , They are happy ... Hawaii, Chef Kathy Morris. Kathy is an extraordinary chef and ...
Breaking Medicine News(10 mins):Health News:Mobile Health Offers Prescription Discount Benefit Cards Saving Patients Up To 50% Off 2Health News:New Device May Show Doctors More of the Colon 2Health News:New Device May Show Doctors More of the Colon 3Health News:Many Can Blame Family for Their Bunions 2Health News:Maui'd Forever Uses New Chef for Receptions and Special Private Beach Dinners 2
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... 17, 2013  Technology advances have had a ... with a constantly evolving communication environment, companies need ... communicating with internal executives. It is challenging, however, ... tactics and tools that are part of today,s ... study, Best Practices, LLC explores the various internal ...
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology Inc. ... Sorter 8-well strip holder and 130um sorting chip.  Sony will ... collected on its new SH800 Cell Sorter, the EC800 flow ... commercial tutorials at CYTO 2013, which will be held at ... San Diego, California , from May 20 ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Delivers New Technology for Science to CYTO 2013 2
Cached News: